Total Payments
$777,138
2024 Payments
$107,679
Companies
45
Transactions
1,218
Medicare Patients
2,265
Medicare Billing
$234,147
Payment Breakdown by Category
Other$650,251 (83.7%)
Travel$80,370 (10.3%)
Food & Beverage$23,164 (3.0%)
Consulting$23,141 (3.0%)
Education$212.68 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $537,225 | 270 | 69.1% |
| Compensation for serving as faculty or as a speaker for a medical education program | $97,222 | 45 | 12.5% |
| Travel and Lodging | $80,370 | 246 | 10.3% |
| Food and Beverage | $23,164 | 622 | 3.0% |
| Consulting Fee | $23,141 | 10 | 3.0% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $15,754 | 15 | 2.0% |
| Education | $212.68 | 9 | 0.0% |
| Long term medical supply or device loan | $49.95 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $274,168 | 318 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $196,111 | 227 | $0 (2024) |
| Amgen Inc. | $127,366 | 187 | $0 (2024) |
| Dexcom, Inc. | $93,883 | 110 | $0 (2024) |
| Abbott Laboratories | $78,668 | 170 | $0 (2024) |
| Medtronic MiniMed, Inc. | $3,542 | 42 | $0 (2020) |
| Kyowa Kirin, Inc. | $307.03 | 6 | $0 (2024) |
| Lilly USA, LLC | $303.93 | 18 | $0 (2024) |
| BETA BIONICS, INC. | $290.54 | 5 | $0 (2024) |
| Insulet Corporation | $229.56 | 11 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $107,679 | 179 | Dexcom, Inc. ($36,910) |
| 2023 | $112,588 | 202 | Dexcom, Inc. ($40,693) |
| 2022 | $85,977 | 158 | Novo Nordisk Inc ($35,494) |
| 2021 | $79,850 | 96 | Novo Nordisk Inc ($42,034) |
| 2020 | $57,805 | 96 | Novo Nordisk Inc ($22,768) |
| 2019 | $133,241 | 187 | Amgen Inc. ($56,807) |
| 2018 | $91,343 | 127 | Novo Nordisk Inc ($48,633) |
| 2017 | $108,656 | 173 | SANOFI-AVENTIS U.S. LLC ($70,719) |
All Payment Transactions
1,218 individual payment records from CMS Open Payments — Page 1 of 49
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $6.97 | General |
| Category: Diabetes Care | ||||||
| 12/24/2024 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $6.77 | General |
| Category: Diabetes Care | ||||||
| 12/20/2024 | Dexcom, Inc. | DEXCOM G7 GSS (161) (Medical Supply) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $1,149.00 | General |
| Category: Endocrinology | ||||||
| 12/19/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $23.34 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/19/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: DIABETES MEDICINE | ||||||
| 12/19/2024 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $6.55 | General |
| Category: Diabetes Care | ||||||
| 12/18/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $23.34 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/17/2024 | Ascendis Pharma Inc | Skytrofa (Drug) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: Endocrinology | ||||||
| 12/16/2024 | Dexcom, Inc. | DEXCOM G7 GSS (161) (Medical Supply) | Travel and Lodging | Cash or cash equivalent | $31.49 | General |
| Category: Endocrinology | ||||||
| 12/13/2024 | Dexcom, Inc. | DEXCOM G7 GSS (161) (Medical Supply) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $1,915.00 | General |
| Category: Endocrinology | ||||||
| 12/13/2024 | Dexcom, Inc. | DEXCOM G7 GSS (161) (Medical Supply) | Food and Beverage | In-kind items and services | $125.01 | General |
| Category: Endocrinology | ||||||
| 12/06/2024 | Dexcom, Inc. | DEXCOM G7 GSS (161) (Medical Supply) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $2,298.00 | General |
| Category: Endocrinology | ||||||
| 12/06/2024 | Dexcom, Inc. | DEXCOM G7 GSS (161) (Medical Supply) | Food and Beverage | In-kind items and services | $152.75 | General |
| Category: Endocrinology | ||||||
| 12/05/2024 | Dexcom, Inc. | DEXCOM G7 GSS (161) (Medical Supply) | Travel and Lodging | In-kind items and services | $1,553.19 | General |
| Category: Endocrinology | ||||||
| 12/03/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $128.49 | General |
| Category: Automated insulin delivery system | ||||||
| 12/03/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: Bone Health | ||||||
| 11/26/2024 | Dexcom, Inc. | DEXCOM G7 GSS (161) (Medical Supply) | Travel and Lodging | Cash or cash equivalent | $474.36 | General |
| Category: Endocrinology | ||||||
| 11/26/2024 | Dexcom, Inc. | DEXCOM G7 GSS (161) (Medical Supply) | Travel and Lodging | Cash or cash equivalent | $17.25 | General |
| Category: Endocrinology | ||||||
| 11/26/2024 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: Diabetes Care | ||||||
| 11/26/2024 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $8.38 | General |
| Category: Diabetes Care | ||||||
| 11/26/2024 | Dexcom, Inc. | DEXCOM G7 GSS (161) (Medical Supply) | Food and Beverage | In-kind items and services | $0.62 | General |
| Category: Endocrinology | ||||||
| 11/21/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $12.87 | General |
| Category: Cardiology | ||||||
| 11/18/2024 | Novo Nordisk Inc | Ozempic (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $750.00 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | Dexcom, Inc. | DEXCOM G7 GSS (161) (Medical Supply) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $3,064.00 | General |
| Category: Endocrinology | ||||||
| 11/14/2024 | Novo Nordisk Inc | Ozempic (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $750.00 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 512 | 869 | $118,870 | $53,712 |
| 2022 | 6 | 604 | 967 | $133,881 | $62,099 |
| 2021 | 7 | 573 | 976 | $134,873 | $65,229 |
| 2020 | 9 | 576 | 910 | $126,275 | $53,108 |
Total Patients
2,265
Total Services
3,722
Medicare Billing
$234,147
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 285 | 520 | $84,760 | $41,038 | 48.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 34 | 43 | $9,417 | $5,109 | 54.2% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 82 | 161 | $14,490 | $3,921 | 27.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 21 | 23 | $2,484 | $1,315 | 52.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 13 | 13 | $3,250 | $1,299 | 40.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 77 | 109 | $4,469 | $1,031 | 23.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 292 | 529 | $86,227 | $43,258 | 50.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 59 | 59 | $14,750 | $6,429 | 43.6% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 78 | 167 | $15,030 | $4,079 | 27.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 22 | 29 | $6,351 | $3,737 | 58.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 58 | 60 | $6,480 | $3,434 | 53.0% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 95 | 123 | $5,043 | $1,162 | 23.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 279 | 532 | $86,716 | $46,497 | 53.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 48 | 48 | $12,000 | $4,973 | 41.4% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2021 | 71 | 170 | $15,300 | $4,302 | 28.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 24 | 31 | $6,789 | $3,969 | 58.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 62 | 67 | $7,236 | $3,763 | 52.0% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 78 | 116 | $4,756 | $1,110 | 23.3% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 11 | 12 | $2,076 | $614.61 | 29.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 193 | 388 | $63,244 | $28,848 | 45.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 130 | 172 | $18,576 | $8,040 | 43.3% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 58 | 58 | $14,500 | $6,554 | 45.2% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2020 | 46 | 90 | $8,100 | $2,377 | 29.3% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 27 | 32 | $5,421 | $1,739 | 32.1% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 15 | 16 | $3,504 | $1,581 | 45.1% |
About Dr. Catherine Kilpatrick, M.D
Dr. Catherine Kilpatrick, M.D is a Internal Medicine healthcare provider based in Fayetteville, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/20/2009. The National Provider Identifier (NPI) number assigned to this provider is 1649407354.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Catherine Kilpatrick, M.D has received a total of $777,138 in payments from pharmaceutical and medical device companies, with $107,679 received in 2024. These payments were reported across 1,218 transactions from 45 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($537,225).
As a Medicare-enrolled provider, Kilpatrick has provided services to 2,265 Medicare beneficiaries, totaling 3,722 services with total Medicare billing of $234,147. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Diabetes & Metabolism|Endocrinology, Diabetes & Metabolism
- Location Fayetteville, AR
- Active Since 06/20/2009
- Last Updated 10/03/2017
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1649407354
Products in Payments
- Ozempic (Drug) $80,020
- DEXCOM G7 GSS (161) (Medical Supply) $77,381
- Prolia (Biological) $65,541
- EVENITY (Biological) $61,568
- SOLIQUA (Drug) $49,630
- RYBELSUS (Drug) $45,761
- TOUJEO (Drug) $44,365
- FREESTYLE LIBRE 3 (Device) $35,691
- SOLIQUA 100/33 (Biological) $35,191
- Rybelsus (Drug) $34,389
- Tresiba (Drug) $30,943
- TZIELD (Biological) $30,802
- FreeStyle Libre Pro (Device) $26,270
- Victoza (Drug) $25,089
- Xultophy 100/3.6 (Drug) $20,085
- Dexcom G6 Transmitter (Medical Supply) $16,464
- SOLIQUA 100/33 (Drug) $12,722
- FREESTYLE LIBRE 2 (Device) $11,856
- TOUJEO (Biological) $11,074
- FREESTYLE LIBRE (Device) $4,594
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Fayetteville
Dr. Eugene Wright, M.d, M.D
Internal Medicine — Payments: $968,535
Internal Medicine $968,535
Dr. Nicole Greyshock, Md, MD
Internal Medicine — Payments: $387,661
Internal Medicine $387,661
Dr. Frederick Asare, Md, MD
Internal Medicine — Payments: $59,642
Internal Medicine $59,642
Sandip Patel, Md, MD
Internal Medicine — Payments: $42,449
Internal Medicine $42,449
Dr. Hari Saini, M.d, M.D
Internal Medicine — Payments: $33,331
Internal Medicine $33,331
Dr. Sumedha Dalvi, M.d, M.D
Internal Medicine — Payments: $31,724
Internal Medicine $31,724